SCHEMBL20205309

SCHEMBL20205309

CC1(C)c2cc3c(cc2-c2c1cc(-c1cccc(-c4ccccc4)c1)c1c2oc2ccccc21)C(C)(C)c1cc(-c2cccc(-c4ccccc4)c2)c2c(oc4ccccc42)c1-3

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 3/20 0.36
▸ PLA2G4A P47712 3/20 0.36
▸ ALOX5 P09917 1/20 0.35
▸ PLA2G10 O15496 1/20 0.34
▸ CDC14B O60729 1/20 0.34
▸ CDC14A Q9UNH5 1/20 0.34
▸ MAPT P10636 6/20 0.33
▸ PGR P06401 1/20 0.33
▸ ALDH1A1 P00352 6/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ HPGD P15428 4/20 0.32
▸ PRKDC P78527 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ CSF1R P07333 1/20 0.32
▸ PDGFRB P09619 1/20 0.32
▸ KIT P10721 1/20 0.32
▸ FLT3 P36888 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ HDAC6 Q9UBN7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20205323 0.96 PLA2G2A (0.34) PLA2G2APLA2G4AALOX5PLA2G10CDC14B
SCHEMBL24649753 0.94 PLA2G2A (0.35) PLA2G2APLA2G4AALOX5PLA2G10CDC14B
SCHEMBL20205319 0.94 CDC14B (0.34) PLA2G2APLA2G4AALOX5CDC14BCDC14A
SCHEMBL20205313 0.93 CDC14B (0.38) PLA2G2APLA2G4AALOX5CDC14BCDC14A
SCHEMBL20205307 0.92 CDC14B (0.39) CDC14BCDC14AMAPTPGRALDH1A1
SCHEMBL24649618 0.92 PGR (0.36) PLA2G2APLA2G4AALOX5CDC14BCDC14A
SCHEMBL20205337 0.92 CDC14B (0.36) PLA2G2APLA2G4AALOX5PLA2G10CDC14B
SCHEMBL23351760 0.92 PLA2G2A (0.33) PLA2G2APLA2G4AALOX5PLA2G10CDC14B
SCHEMBL20205333 0.91 PLA2G2A (0.36) PLA2G2APLA2G4AALOX5PLA2G10CDC14B
SCHEMBL24649724 0.91 CDC14B (0.33) PLA2G2APLA2G4AALOX5PLA2G10CDC14B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) MERCK PATENT GMBH (DE) 2022-09-27 — — US disclosed
WO-2018095940-A1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2018-05-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) OCIAD2, OCIAD1, JUND PLA2G2A 1854/4885PLA2G4A 2777/4885ALOX5 354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback